Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.
(2015) In Expert Review of Molecular Diagnostics 15(11). p.1409-1410- Abstract
- Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8152368
- author
- Borrebaeck, Carl LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Expert Review of Molecular Diagnostics
- volume
- 15
- issue
- 11
- pages
- 1409 - 1410
- publisher
- Future Drugs Ltd
- external identifiers
-
- pmid:26465682
- wos:000364630600002
- scopus:84947127390
- pmid:26465682
- ISSN
- 1744-8352
- DOI
- 10.1586/14737159.2015.1100499
- language
- English
- LU publication?
- yes
- id
- 2cdfc040-76a2-4ae0-80fb-7bd36018b005 (old id 8152368)
- date added to LUP
- 2016-04-01 11:17:21
- date last changed
- 2022-04-28 08:45:40
@misc{2cdfc040-76a2-4ae0-80fb-7bd36018b005, abstract = {{Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.}}, author = {{Borrebaeck, Carl}}, issn = {{1744-8352}}, language = {{eng}}, number = {{11}}, pages = {{1409--1410}}, publisher = {{Future Drugs Ltd}}, series = {{Expert Review of Molecular Diagnostics}}, title = {{Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.}}, url = {{http://dx.doi.org/10.1586/14737159.2015.1100499}}, doi = {{10.1586/14737159.2015.1100499}}, volume = {{15}}, year = {{2015}}, }